Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Corona Remedies Limited Call Transcript 2026

Apr 30, 2026

59164_rns_2026-04-30_9e6cfe64-abf4-4efb-b5d8-bf1eba9500fb.pdf

Call Transcript

Open in viewer

Opens in your device viewer

CORONA

CORONA Remedies Limited

(Formerly known as CORONA Remedies Private Limited)

Regd. Office: CORONA House

C- Mondeal Business Park, Near Gurudwara, S.G. Highway,

Thaltej, Ahmedabad 380 059. Gujarat, India.

Tele.: +079 - 40233000

Online at: [email protected]

website: www.coronaremedies.com

CIN: L24231GJ2004PLC044656

April 30, 2026

To,

Listing Operation Department

BSE Limited

Phiroze Jeejeebhoy Towers,

Dalal Street, Mumbai – 400001

(Scrip Code: 544644)

To,

Listing Compliance Department

National Stock Exchange of India Limited

Exchange Plaza, C-1, Block G, Bandra Kurla

Complex, Bandra (East), Mumbai- 400051

(SYMBOL: CORONA)

Dear Sir / Madam,

Sub.: Intimation of Schedule of Analyst / Investor Call

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that the Company will hold its Q4 FY26 earnings conference call (i.e. post earnings/quarterly call) on Tuesday, May 12, 2026 at 11:00 a.m. (IST) to discuss the financial results of the Company for the fourth quarter and year ended March 31, 2026 as per details enclosed herewith.

This intimation is also being made available on the website of the Company at www.coronaremedies.com

You are requested to take note of the above.

Thanking you.

Your faithfully,

For CORONA Remedies Limited

CHETNA PRABHAT
KUMAR DHARAJIYA
Digitally signed by CHETNA
PRABHAT KUMAR DHARAJIYA
Date: 2026.04.30 15:41:21
+05'30'

Chetna Dharajiya
Company Secretary and Compliance Officer

Encl.: A/a


AMBIT
Acumen at work
Institutional Equities
CORONA

Q4FY26 Earnings Call

CORONA Remedies Limited

May 12, 2026 at 11:00 AM (IST)

Ambit Capital cordially invites you to the Q4FY26 Earnings Call of CORONA Remedies Limited

Company Representatives

Mr. Nirav Mehta - Managing Director & CEO
Mr. Ankur Mehta - Joint Managing Director
Mr. Bhavin Bhagat - Chief Financial Officer

The teleconference will be moderated by Gaurav Tinani, Institutional Equities, Ambit Capital.

Conference Call Details

Date: May 12, 2026 | Time: 11:00 AM (IST)

Please join the conference via Diamond Pass to avoid wait time. Please click here to register.
Primary Access Numbers +91 22 6280 1148
+91 22 7115 8049
International Toll Free Numbers Singapore: 800 101 2045
Hong Kong: 800 964 448
USA: 1 866 746 2133
UK: 0 808 101 1573
We request you to dial in a few minutes prior to the scheduled time.